Related Experiment Video
Updated: Jun 30, 2025
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.0K
Navigating late-stage dementia: A perspective from the Alzheimer's Association
Kristen Clifford1, Monica Moreno1, Courtney M Kloske1
1Alzheimer's Association Chicago Illinois USA.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|March 18, 2024
Summary
This article addresses late-stage Alzheimer's disease (AD) care, offering the Alzheimer's Association's perspective on crucial factors like advanced directives and palliative care for dementia patients.
Area of Science:
- Neurology
- Geriatrics
- Palliative Care
Background:
- Alzheimer's disease (AD) is the leading cause of dementia, impacting cognitive abilities and daily functioning.
- Late-stage AD necessitates intensive, continuous care, often around the clock.
- The Alzheimer's Association supports individuals with AD, their caregivers, and healthcare providers through care decisions.
Purpose of the Study:
- To present the Alzheimer's Association's viewpoint on critical aspects of late-stage dementia care.
- To respond to recent publications that diverge from the Association's established stance.
- To explore diverse perspectives within the field of late-stage dementia care.
Main Methods:
- Review and synthesis of the Alzheimer's Association's position on late-stage AD care.
- Analysis of key considerations including advanced directives, palliative care, nutrition, and legal aspects.
- Inclusion of contrasting viewpoints from the scientific community.
Main Results:
- The article outlines the Association's perspective on essential elements for managing late-stage Alzheimer's disease.
- It highlights differing viewpoints on dementia care strategies.
- Resources available through the Alzheimer's Association are detailed.
Conclusions:
- The article aims to provide a comprehensive overview of late-stage dementia care.
- It emphasizes the importance of supporting individuals with AD, their care partners, and healthcare providers.
- It seeks to foster informed decision-making throughout the continuum of Alzheimer's disease care.
Related Concept Videos
01:26Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
01:22Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
01:30Cognitive Development During Adulthood
98
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
98
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
01:21Kubler Ross's Stages of Dying
69
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
69